The mission of hDMT, the Institute for human organ and Disease Model Technologies, is to develop and qualify cell culture models that mimic healthy and diseased human tissues based on Organ-on-Chip technology, and to facilitate their valorization and implementation.
hDMT is a consortium, consisting of the hDMT foundation and 17 partner organizations, including (technical) universities, university medical centers and knowledge institutes. Researchers from different disciplines, varying from technologists and biologists to pharmacologists and clinicians, share their complementary expertise, facilities and ideas as a community. Research is done by the partners and the partners are supported by the foundation. hDMT is a not-for-profit organization with the policy of open access publication, which makes use of the partner infrastructure.
Valorization of research results occurs through a growing network of companies, that collaborate with hDMT partners in specific projects. In addition, hDMT has built partnerships with strong Dutch consortia (e.g. RegMedXB, OnePlanet, HighTechNL, Nano4Society, HollandBio, MinacNed, NanoNextNL) and collaborates with the Proefdiervrij Foundation, (Association of) Dutch Health Foundations and governmental organizations, including Ministries, Topsectors Life Science and Health (LSH) and High Tech Systems and Materials (HTSM), ZonMw, NWO, Dutch Enterprise Agency (RVO) and the National Institute for Public Health and the Environment (RIVM).